A second dose of Covaxin for children ages 6 to 12, one step further in the fight against corona | Coronavirus-latest-news
Bharat Biotech started testing the vaccine on children in June. These children have now been given a second dose.
New Delhi, July 19 : With the third wave of corona in the country (Third wave of Corona virus) Of young children while preparing to fight (Vaccination of children) India has reached another milestone in vaccination trials. India Biotech (Bharat Biotech) The company began testing the vaccine on young children in June. These children now have a second dose (Second dose) Has been given. This is a major step in the journey of getting children between the ages of 6 and 12 vaccinated.
Children between the ages of 6 and 12 have been given a second dose of the covacin vaccine, while children between the ages of 2 and 6 will receive a second dose next week. The effectiveness of these vaccines will become clear after the reports of these two tests are received. The impact of the third wave of corona can hit young children, a warning that has been given many times before. Against this backdrop, it is predicted that vaccination of children will begin with the third wave.
Read this -Explainer: The third wave of corona? What exactly do the statistics indicate?
Also equipped with Zydus candles
All tests for the Zydus candy vaccine have been completed. The vaccine is expected to be available in the market soon after the official approval process is completed. It is currently being speculated to be the first vaccine to be made available to individuals under the age of 18 in India. The vaccine is expected to be available in the market before Bharat Biotech’s covacin. Zydus candy vaccine tests have been completed. The vaccine has been tested on a total of 28,000 volunteers and has been shown to help produce antibodies in the body of children between the ages of 12 and 18. If the vaccine is approved, Zydus will be the fifth company to supply the vaccine in the country. Covishield, Kovacin, Sputnik-V, and Mordana vaccines have been approved in the United States.